A Growing Body
of Evidence
Browse the expanding collection of published research featuring our seed amplification assay (SAA) technology.
Scientific Paper
Alzheimer's & Dementia
Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study
June 15, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Atrophy signature for alpha-synuclein copathology in Alzheimer's disease
May 24, 2026
Read MoreScientific Paper
Neurobioogy of Disease
Combination of CSF α-synuclein seed amplification assay and amyloid-β42 predicts cognitive decline in Parkinson's disease
May 16, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging
May 3, 2026
Read MoreScientific Paper
Alzheimer's & Dementia
Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort
March 24, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Faster reaction times of CSF alpha-synuclein seed amplification assay predict the diffuse malignant subtype of Parkinson's disease at 10-year follow-up
January 29, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants
January 23, 2026
Read MoreScientific Paper
Neurobiology of Disease
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease
January 1, 2026
Read MoreScientific Paper
Molecular Psychiatry
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer's disease continuum
December 14, 2025
Read MoreScientific Paper
Movement disorders
Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice
December 9, 2025
Read MoreScientific Paper
The Lancet Neurology
Unlocking the full clinical potential of the α-synuclein seed amplification assay
July 1, 2025
Read MoreScientific Paper
The Lancet Neurology
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study
July 1, 2025
Read MoreScientific Paper
Brain
The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients
January 31, 2025
Read MoreScientific Paper
Journal of Movement Disorders
Cardiac 123I-meta-iodobenzylguanidine Imaging as a Biomarker for Body-first Parkinson’s Disease: Linking Peripheral α-Synuclein to Clinical Subtyping
August 4, 2025
Read MoreScientific Paper
Nature Communications
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification
August 5, 2025
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
